FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2312895077> ?p ?o ?g. }

• W2312895077 endingPage "277" @default.
• W2312895077 startingPage "271" @default.
• W2312895077 abstract "The aim of the study was to determine treatment outcome and identify a particularly high risk group in a consecutive series of 66 patients with poor prognosis high grade lymphoma (NHL) treated with conventional induction chemotherapy followed by high-dose chemotherapy (HDCT) and peripheral blood stem cells (PBSC) rescue. Fifty-one patients with intermediate grade NHL (Kiel) and two or three adverse prognostic features as defined by the age-adjusted International Prognostic Index (IPI) received induction treatment with 7 weeks of doxorubicin, cyclophosphamide, vincristine, bleomycin, etoposide, prednisolone and methotrexate (VAPEC-B) followed by three cycles of ifosfamide/cytarabine. Fifteen patients with high grade Burkitt's and lymphoblastic NHL received 11 weeks of VAPEC-B followed by three cycles of high-dose methotrexate. HDCT for all 66 patients consisted of busulphan/cyclophosphamide followed by autologous PBSC rescue. Thirty-one patients (47%) received HDCT in first complete remission (CR/CRu) and 34 patients (52%) in first partial remission (PR) after conventional chemotherapy. Following HDCT, 42 patients (64%) were in CR/CRu, 19 patients (29%) in PR and one patient had progressive disease. There were four toxic deaths. After a median follow-up period of 27 months (range 7-73) in 46 surviving patients, the actuarial 3-year estimates of overall survival, event-free survival (EFS) and freedom from progression (FFP) were 67%, 65% and 70%, respectively. In univariate analysis, prognostic factors associated with reduced EFS were mediastinal bulk (P = 0.02), > or = 3 extra-nodal sites (P = 0.02), remission status prior to HDCT (P = 0.05), low albumin (P = 0.08) and raised ESR (P = 0.09). No significant difference was observed between patients with intermediate or high grade NHL or between patients with two or three adverse IPI features. Multivariate analysis identified mediastinal bulk (P = 0.01), > or = 3 extra-nodal sites (P = 0.01) and low albumin (P = 0.03) as joint predictors of poor EFS. Remission status prior to HDCT was not found to be significantly associated with reduced EFS, FFP or survival, suggesting early introduction of HDCT may benefit patients with a PR. Based on these three adverse features, three groups (0, 1 or > or = 2 features) could be identified with differing EFS, survival and freedom from progression (FFP) rates at 3 years; 85%, 63% and 20%, respectively for EFS, 84%, 64% and 25% for survival and 85%, 66% and 33%, respectively for FFP. This prognostic model may identify patients with a particularly poor prognosis despite HDCT, who may benefit from other therapeutic approaches." @default.
• W2312895077 created "2016-06-24" @default.
• W2312895077 creator A5011398209 @default.
• W2312895077 creator A5021845898 @default.
• W2312895077 creator A5023781617 @default.
• W2312895077 creator A5048763179 @default.
• W2312895077 creator A5066736483 @default.
• W2312895077 creator A5083050158 @default.
• W2312895077 creator A5084782122 @default.
• W2312895077 date "1999-07-23" @default.
• W2312895077 modified "2023-10-14" @default.
• W2312895077 title "Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin’s lymphoma" @default.
• W2312895077 doi "https://doi.org/10.1038/sj.bmt.1701894" @default.
• W2312895077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10455365" @default.
• W2312895077 hasPublicationYear "1999" @default.
• W2312895077 type Work @default.
• W2312895077 sameAs 2312895077 @default.
• W2312895077 citedByCount "19" @default.
• W2312895077 countsByYear W23128950772015 @default.
• W2312895077 countsByYear W23128950772021 @default.
• W2312895077 crossrefType "journal-article" @default.
• W2312895077 hasAuthorship W2312895077A5011398209 @default.
• W2312895077 hasAuthorship W2312895077A5021845898 @default.
• W2312895077 hasAuthorship W2312895077A5023781617 @default.
• W2312895077 hasAuthorship W2312895077A5048763179 @default.
• W2312895077 hasAuthorship W2312895077A5066736483 @default.
• W2312895077 hasAuthorship W2312895077A5083050158 @default.
• W2312895077 hasAuthorship W2312895077A5084782122 @default.
• W2312895077 hasBestOaLocation W23128950771 @default.
• W2312895077 hasConcept C126322002 @default.
• W2312895077 hasConcept C141071460 @default.
• W2312895077 hasConcept C144301174 @default.
• W2312895077 hasConcept C2776611710 @default.
• W2312895077 hasConcept C2776694085 @default.
• W2312895077 hasConcept C2776755627 @default.
• W2312895077 hasConcept C2778041864 @default.
• W2312895077 hasConcept C2778119113 @default.
• W2312895077 hasConcept C2778476033 @default.
• W2312895077 hasConcept C2779429289 @default.
• W2312895077 hasConcept C38180746 @default.
• W2312895077 hasConcept C71924100 @default.
• W2312895077 hasConcept C90924648 @default.
• W2312895077 hasConceptScore W2312895077C126322002 @default.
• W2312895077 hasConceptScore W2312895077C141071460 @default.
• W2312895077 hasConceptScore W2312895077C144301174 @default.
• W2312895077 hasConceptScore W2312895077C2776611710 @default.
• W2312895077 hasConceptScore W2312895077C2776694085 @default.
• W2312895077 hasConceptScore W2312895077C2776755627 @default.
• W2312895077 hasConceptScore W2312895077C2778041864 @default.
• W2312895077 hasConceptScore W2312895077C2778119113 @default.
• W2312895077 hasConceptScore W2312895077C2778476033 @default.
• W2312895077 hasConceptScore W2312895077C2779429289 @default.
• W2312895077 hasConceptScore W2312895077C38180746 @default.
• W2312895077 hasConceptScore W2312895077C71924100 @default.
• W2312895077 hasConceptScore W2312895077C90924648 @default.
• W2312895077 hasIssue "3" @default.
• W2312895077 hasLocation W23128950771 @default.
• W2312895077 hasLocation W23128950772 @default.
• W2312895077 hasOpenAccess W2312895077 @default.
• W2312895077 hasPrimaryLocation W23128950771 @default.
• W2312895077 hasRelatedWork W2047930003 @default.
• W2312895077 hasRelatedWork W2063116093 @default.
• W2312895077 hasRelatedWork W2116674414 @default.
• W2312895077 hasRelatedWork W2121694206 @default.
• W2312895077 hasRelatedWork W2122995772 @default.
• W2312895077 hasRelatedWork W2183352065 @default.
• W2312895077 hasRelatedWork W2252336101 @default.
• W2312895077 hasRelatedWork W2401224456 @default.
• W2312895077 hasRelatedWork W2412181118 @default.
• W2312895077 hasRelatedWork W2886757491 @default.
• W2312895077 hasVolume "24" @default.
• W2312895077 isParatext "false" @default.
• W2312895077 isRetracted "false" @default.
• W2312895077 magId "2312895077" @default.
• W2312895077 workType "article" @default.